In children aged 6 to <12 years with obesity, liraglutide (3.0 mg daily, combined with lifestyle interventions) significantly reduced BMI and body weight compared to placebo with lifestyle interventions, though it was associated with increased gastrointestinal side effects.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
CATEGORIES
© 2024-2026 Hormone Insight. All rights reserved.